BMS-986158 [Ligand Id: 11757] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL4297458 (Bet inhibitor bms-986158, Bms-986158, BMS-986158, Ezobresib)
  • bromodomain containing 2/Bromodomain-containing protein 2 in Human [ChEMBL: CHEMBL1293289] [GtoPdb: 1944] [UniProtKB: P25440]
There should be some charts here, you may need to enable JavaScript!
  • bromodomain containing 3/Bromodomain-containing protein 3 in Human [ChEMBL: CHEMBL1795186] [GtoPdb: 2725] [UniProtKB: Q15059]
There should be some charts here, you may need to enable JavaScript!
  • bromodomain containing 4/Bromodomain-containing protein 4 in Human [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
bromodomain containing 2/Bromodomain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293289] [GtoPdb: 1944] [UniProtKB: P25440]
ChEMBL Inhibition of human BRD2 measured by TR-FRET assay B 8.85 pIC50 1.4 nM IC50 J Med Chem (2021) 64: 14247-14265 [PMID:34543572]
bromodomain containing 3/Bromodomain-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795186] [GtoPdb: 2725] [UniProtKB: Q15059]
ChEMBL Inhibition of human BRD3 measured by TR-FRET assay B 8.96 pIC50 1.1 nM IC50 J Med Chem (2021) 64: 14247-14265 [PMID:34543572]
bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885]
ChEMBL Inhibition of human BRD4 (1 to 477 residues) measured after 60 mins by TR-FRET assay B 8.96 pIC50 1.1 nM IC50 J Med Chem (2021) 64: 14247-14265 [PMID:34543572]
ChEMBL Inhibition of N-terminal His6-tagged recombinant human BRD4 (44 to 168 residues) expressed in Escherichia coli BL21 (DE3) incubated for 60 mins by TR-FRET assay B 8.96 pIC50 1.1 nM IC50 ACS Med Chem Lett (2022) 13: 1165-1171 [PMID:35859878]
GtoPdb Time-resolved FRET binding assay using hBRD4 BD-1 bromodomain. - 8.96 pIC50 1.1 nM IC50 J Med Chem (2009) 52: 6527-30 [PMID:19821562]
ChEMBL Inhibition of BRD4 (unknown origin) B 9.1 pIC50 0.8 nM IC50 Bioorg Med Chem Lett (2021) 51: 128376-128376 [PMID:34560263]
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809]
ChEMBL Inhibition of human ERG by flux assay B 4.1 pIC50 >80000 nM IC50 J Med Chem (2021) 64: 14247-14265 [PMID:34543572]
ChEMBL Inhibition of human ERG by patch-clamp assay B 4.55 pIC50 28000 nM IC50 J Med Chem (2021) 64: 14247-14265 [PMID:34543572]
Myc proto-oncogene protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250348] [UniProtKB: P01106]
ChEMBL Inhibition of c-MYC (unknown origin) B 9.15 pIC50 0.7 nM IC50 Bioorg Med Chem Lett (2021) 51: 128376-128376 [PMID:34560263]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]